Review
Published on 21 Sep 2023
Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1225951
- 7,221 views
- 8 citations


